Mesoblast
MESO
39 hedge funds and large institutions have $10.1M invested in Mesoblast in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 3 closing their positions.
467% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 3
333% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 3
84% more capital invested
Capital invested by funds: $5.48M → $10.1M (+$4.62M)
50% more funds holding
Funds holding: 26 → 39 (+13)
38% more call options, than puts
Call options by funds: $3.22M | Put options by funds: $2.34M
0.03% more ownership
Funds ownership: 0.1% → 0.13% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$575K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$565K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$528K |
| 4 |
BlackRock
New York
|
+$406K |
| 5 |
Jane Street
New York
|
+$398K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Regal Partners
Sydney, NSW,
Australia
|
-$587K |
| 2 |
HF
HRT Financial
New York
|
-$289K |
| 3 |
Millennium Management
New York
|
-$76.5K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$41.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17.1K |
MESO Hedge Fund Activity: Q2 2024 in Review
39 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2024, worth a combined $10.1M — up 84% from $5.48M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MESO positions and 3 closed out — a net gain of 14 holders — while 13 added to existing stakes and 3 trimmed.
The largest buyer was Group One Trading, adding an estimated $575K. The largest seller was Regal Partners, exiting entirely with an estimated $587K sold.
- 39 institutional investors held Mesoblast (MESO) as of Q2 2024, up from 26 in Q1 2024.
- Funds reported $10.1M of Mesoblast stock for Q2 2024, up 84% quarter-over-quarter.
- 17 funds opened new Mesoblast positions in Q2 2024 and 3 closed out, a net change of +14 holders.
- The largest Mesoblast buyer in Q2 2024 was Group One Trading, an estimated $575K added.
- The largest Mesoblast seller in Q2 2024 was Regal Partners, an estimated $587K sold.
Based on aggregated 13F filings for Q2 2024.